Targeting cereblon in AML
Blood
.
2021 Feb 4;137(5):584-586.
doi: 10.1182/blood.2020009827.
Author
Steven Grant
1
Affiliation
1
Virginia Commonwealth University.
PMID:
33538804
PMCID:
PMC9710192
DOI:
10.1182/blood.2020009827
No abstract available
Publication types
Comment
MeSH terms
Humans
Lenalidomide
Leukemia, Myeloid, Acute* / drug therapy
Leukemia, Myeloid, Acute* / genetics
Stem Cells
Thalidomide
Ubiquitin-Protein Ligases*
Substances
Thalidomide
Ubiquitin-Protein Ligases
Lenalidomide
Grants and funding
R01 CA205607/CA/NCI NIH HHS/United States